RadNet Inc
NASDAQ:RDNT

Watchlist Manager
RadNet Inc Logo
RadNet Inc
NASDAQ:RDNT
Watchlist
Price: 71.475 USD -3.33%
Market Cap: 5.5B USD
Section:
 

Relative Value

The Relative Value of one RDNT stock under the Base Case scenario is hidden USD. Compared to the current market price of 71.475 USD, RadNet Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RDNT Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

2.8
P/S
P/S
Price to Sales
2.8
vs History
6
vs Industry
48
Median 3Y
2.1
Median 5Y
1.3
Industry
2.3
Forward
2.7
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
0
Median 3Y
94.2
Median 5Y
56.6
Industry
22.4
Forward
203.7
More Details
21.4
P/OCF
P/OCF
Price to OCF
21.4
vs History
4
vs Industry
25
Median 3Y
15.7
Median 5Y
10.7
Industry
14.4
More Details
102.1
P/FCFE
P/FCFE
Price to FCFE
102.1
vs History
4
vs Industry
18
Median 3Y
-17.5
Median 5Y
13.8
Industry
21.5
More Details
5.2
P/B
P/B
Price to Book Value
5.2
vs History
36
vs Industry
21
Median 3Y
4.5
Median 5Y
4.9
Industry
2.2
More Details
2.9
EV/S
EV/S
Enterprise Value to Sales
2.9
vs History
6
vs Industry
47
Median 3Y
2.2
Median 5Y
1.8
Industry
2.5
Forward
2.8
More Details
13.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
13.7
vs History
6
vs Industry
25
Median 3Y
10.1
Median 5Y
8.3
Industry
5.1
More Details
31.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
31.9
vs History
4
vs Industry
28
Median 3Y
16.4
Median 5Y
14.1
Industry
12
Forward
19
More Details
73.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
73.7
vs History
11
vs Industry
13
Median 3Y
42.1
Median 5Y
41.2
Industry
17.1
Forward
55.6
More Details
22.3
EV/OCF
EV/OCF
Enterprise Value to OCF
22.3
vs History
4
vs Industry
25
Median 3Y
16.6
Median 5Y
14.9
Industry
14.7
More Details
110.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
110.3
vs History
14
vs Industry
5
Median 3Y
68.9
Median 5Y
61.3
Industry
18.8
More Details
2.4
EV/IC
EV/IC
Enterprise Value to IC
2.4
vs History
7
vs Industry
41
Median 3Y
1.9
Median 5Y
1.4
Industry
1.8
More Details

Multiples Across Competitors

RDNT Competitors Multiples
RadNet Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
RadNet Inc
NASDAQ:RDNT
5.5B USD 2.8 -433.2 31.9 73.7
US
CVS Health Corp
NYSE:CVS
101.1B USD 0.3 215.9 14.1 14.1
US
Cigna Corp
NYSE:CI
73.6B USD 0.3 12 7.7 9.8
US
Cigna Group
XMUN:CGN
62.2B EUR 0.3 11.9 7.7 9.7
DE
Fresenius SE & Co KGaA
XETRA:FRE
27.3B EUR 1.2 23.9 10.4 15.9
DE
Fresenius Medical Care AG
XMUN:FME
23.2B EUR 1.2 32.3 10.2 21.8
US
Laboratory Corporation of America Holdings
NYSE:LH
21.7B USD 1.6 25.4 13.8 19.2
US
Quest Diagnostics Inc
NYSE:DGX
20.3B USD 1.9 21.1 11.6 15.7
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.6B EUR 0.6 16.2 6.4 13.6
US
Guardant Health Inc
NASDAQ:GH
12.9B USD 14.3 -32.5 -34.2 -31.1
US
DaVita Inc
NYSE:DVA
8.5B USD 0.6 11.1 6.8 9.3
P/E Multiple
Earnings Growth PEG
US
RadNet Inc
NASDAQ:RDNT
Average P/E: 41.1
Negative Multiple: -433.2
203%
N/A
US
CVS Health Corp
NYSE:CVS
215.9
31%
7
US
Cigna Corp
NYSE:CI
12
39%
0.3
US
C
Cigna Group
XMUN:CGN
11.9
39%
0.3
DE
Fresenius SE & Co KGaA
XETRA:FRE
23.9
71%
0.3
DE
Fresenius Medical Care AG
XMUN:FME
32.3
37%
0.9
US
Laboratory Corporation of America Holdings
NYSE:LH
25.4
30%
0.8
US
Quest Diagnostics Inc
NYSE:DGX
21.1
14%
1.5
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
16.2
37%
0.4
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -32.5 N/A N/A
US
DaVita Inc
NYSE:DVA
11.1
4%
2.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
RadNet Inc
NASDAQ:RDNT
Average EV/EBITDA: 12.1
31.9
18%
1.8
US
CVS Health Corp
NYSE:CVS
14.1
25%
0.6
US
Cigna Corp
NYSE:CI
7.7
4%
1.9
US
C
Cigna Group
XMUN:CGN
7.7
4%
1.9
DE
Fresenius SE & Co KGaA
XETRA:FRE
10.4
14%
0.7
DE
Fresenius Medical Care AG
XMUN:FME
10.2
10%
1
US
Laboratory Corporation of America Holdings
NYSE:LH
13.8
16%
0.9
US
Quest Diagnostics Inc
NYSE:DGX
11.6
8%
1.5
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
6.4
10%
0.6
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -34.2 N/A N/A
US
DaVita Inc
NYSE:DVA
6.8
4%
1.7

See Also

Summary
RDNT intrinsic value, competitors valuation, and company profile.
DCF Valuation
RDNT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RDNT stock valuation using valuation multiples.
Wall Street Estimates
RDNT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RDNT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 303,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.